SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-038341
Filing Date
2011-02-17
Accepted
2011-02-17 06:31:12
Documents
4
Period of Report
2011-02-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 16879
2 PRESS RELEASE DATED FEBRUARY 17, 2011 ANNOUNCING FINANCIAL RESULTS dex991.htm EX-99.1 79977
3 PRESS RELEASE DATED FEBRUARY 17, 2011 ANNOUNCING CORPORATE RESTRUCTURING dex992.htm EX-99.2 12445
4 GRAPHIC g152347ex99.jpg GRAPHIC 24952
  Complete submission text file 0001193125-11-038341.txt   145403
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31577 | Film No.: 11619220
SIC: 2834 Pharmaceutical Preparations